aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company (“aVenture”) is an independent research platform providing information and analysis about startups.
Certain metrics provided by aVenture may seek to assess the risks and opportunities associated with a company, fund, or its representatives (collectively “research”). aVenture seeks to provide this information with objectivity and fairness, and with diligence about its accuracy. Nonetheless, aVenture cannot provide assurance as to the accuracy of the information provided by our research. We strongly advise those using the research platform to seek multiple, independent sources for your research when making financial decisions.
Any links provided to other websites are offered as a matter of convenience and are not intended to imply that aVenture or its authors endorse, sponsor, promote, and/or are affiliated with the owners of or participants in those sites.
The aVenture platform also provides investment listings offered by independent investment advisers in the United States. aVenture is neither a registered investment adviser nor an exempt reporting adviser under the Investment Advisers Act of 1940, and no statements made by aVenture are intended to imply any financial instruments are under the counsel or advice of aVenture or its representatives.
Funds offered on the platform are generally managed by a private investment adviser that, unless stated otherwise, claims exemption from SEC or state registration. Investment funds presented on the platform are only available to investors who meet the requirements of the offering, and solicitations are not made outside those listed jurisdictions.
Additionally, each investment offered on the platform has qualifications for eligibility, including some offered only to Qualified Clients and/or Accredited Investors. Certain funds may be available to non-Qualified or Accredited investors, but only those who become personally known and identifiable to aVenture Investment Company staff, who have had an opportunity to assess the financial capacity and suitability for such an investment, and discuss its risks. Funds, when offered, are only offered following a review of a Private Placement Memorandum (PPM), subscription agreement, and other disclosures.
Investments in startups, venture capital, angel investments, private equity, real estate, stocks, and similar asset classes all involve risks, including: the risk of a decline in the value of your investments, including potentially large declines (suddenly and/or for long periods of time), the potential for illiquidity where part or all of a withdrawal request may not be honored on the date requested (even when a feature of the fund). These risks are heightened during periods of market duress.
Diversification has the possibility of reducing the magnitude of declines (either caused by market/economic factors, or by factors related to the individual company), but does not guarantee these risks have been fully or partially alleviated. Most importantly, past results are not an assurance of future outcomes. While most of these risks are shared and similarly held by other investment asset classes, we recommend investors only consider venture capital investments as part of a broader, diversified portfolio of stocks, bonds, and immediately accessible cash reserves.
From Startups | TechCrunch
By Rebecca Szkutak
April 11, 2024
Venture secondaries has exploded over the last couple of years. While some firms have used the increase in activity to build up their positions in their most promising portfolio companies, Airtree Ventures is taking advantage of the momentum a little differently.
The Sydney-based venture firm, founded in 2014, has been using company-led secondary sales to slim down its equity stakes and get liquidity from some of its most promising bets. The company’s portfolio is made up of Australian unicorns including Canva, last valued at $40 billion, Immutable, $2.4 billion, and LinkTree, $1.3 billion, among others.
Craig Blair, a co-founder and partner at Airtree, told TechCrunch that not unlike other venture firms, Airtree’s goal is to deliver the maximum level of returns to its investors. But unlike many other firms, Airtree generates returns throughout the whole lifecycle of an investment, rather than just when the company exists.
“Right from the start, we want to put as much energy and thought into the exit process that we do for the funding process,” Blair said. “We look at the lifecycles of the fund, we look at businesses themselves, and think about when could be a good time to exit that business.”
Airtree backs companies at the pre-seed and seed stage; as companies stay private for longer, they aren’t returning money as often during the traditional fund lifecycle. So in 2021 Airtree started seeking out alternative ways to get liquidity for some of their earliest stakes, Blair said.
One of which was Canva. Airtree originally invested in Canva’s $6 million Series A round in 2015. Blair said the firm slimmed down its stake in the startup in 2021 when the company was valued at $39 billion. Airtree got a 1.4x return on Fund I from this transaction alone and was able to maintain the majority of their original stake.
“There is no hard and fast rule,” Blair said on how the firm decides when to slim down its stakes. “We look at the position of the fund and the role of that company in that fund [and think], ‘If we sold today at that price, what sort of future value are we giving up that we could hold? [What is] the value of liquidity versus long term TVPI and the effect on the fund?'”
Each time Airtree has done this, it’s purposefully maintained a majority of their stake, Blair said. He said the firm still wants to get that huge win at the end, but doesn’t want to put “all their eggs into that final basket.”
This strategy makes a lot of sense looking at how far some of the valuations for late-stage startups have fallen over the last few years. While some companies are working to grow into their last valuation, many have a long way to go and may still exit for lower than they raised their last primary round.
But Airtree’s strategy isn’t foolproof, and many investors would likely argue that slimming down these stakes takes money off the table. They aren’t wrong, and Blair acknowledges that when a company does eventually exit, Airtree makes less money off of it because of this strategy. However, that final exit isn’t guaranteed to be strong, either, he said.
Blair said Airtree wouldn’t rule out raising a continuation fund — the venture industry’s current liquidity vehicle of choice — and said it may make sense if the firm wants to start selling a bundle of its shares at once. But its current secondary strategy of raising its hand when companies look to run secondary tender sales has worked out well for them thus far.
“I’d say our responsibility as investors is to return money to our LPs at the right time,” Blair said. “Selling too early can be bad, for sure. There isn’t a single answer but rather having a process about having active decisions and not passive decisions [about liquidity]. Don’t just sit back and wait for [exits] to happen to you.”
View original article on techcrunch.com
Share:
Xaira, an AI drug discovery startup, launches with a massive $1B, says it’s ‘ready’ to start developing drugs
Advances in generative AI have taken the tech world by storm. Biotech investors are making a big bet that similar computational methods could revolutionize drug discovery. On Tuesday, ARCH Venture Partners and Foresite Labs, an affiliate of Foresite Capital, announced that they incubated Xaira Therapeutics and funded the AI biotech with $1 billion. Other investors […] © 2024 TechCrunch. All rights reserved. For personal use only.
Apr 25, 2024
Eric Schmidt-backed Augment, a GitHub Copilot rival, launches out of stealth with $252M
AI is supercharging coding — and developers are embracing it. In a recent StackOverflow poll, 44% of software engineers said that they use AI tools as part of their development processes now and 26% plan to soon. Gartner estimates that over half of organizations are currently piloting or have already deployed AI-driven coding assistants, and […] © 2024 TechCrunch. All rights reserved. For personal use only.
Apr 24, 2024
Radical thinks the time has come for solar-powered, high-altitude autonomous aircraft
Though many eyes are on space as orbit develops into a thriving business ecosystem, Radical is keeping things a little closer to the ground — but not too close. Its high-altitude, solar-powered aircraft aim to succeed where Facebook’s infamous Aquila failed by refining the tech and embracing more markets. It’s hard to believe that Facebook’s […] © 2024 TechCrunch. All rights reserved. For personal use only.
Apr 24, 2024
Don't miss our latest news and updates. Subscribe to the newsletter
More from Tech Crunch: